🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 84 of 200 · A–Z by INN

  1. ginsenoside-rd

    NMPA: clinical trials

  2. givinostat

    DUVYZAT

    EMA: approved

    M09AX14

  3. givinostat hydrochloride

    DUVYZAT

    ORAL FDA: approved

  4. givosiran

    GIVLAARI Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    A16AX16

  5. givosiran sodium

    GIVLAARI Alnylam Netherlands B.V.

    SUBCUTANEOUS FDA: approved

  6. glargine

    NMPA: clinical trials

  7. glasdegib

    DAURISMO

    EMA: approved

    L01XX63

  8. glasdegib maleate

    DAURISMO

    ORAL FDA: approved

  9. glatiramer acetate

    COPAXONE Lacuna Pharma Pty Ltd

    SUBCUTANEOUS FDA: approved · TGA: approved

  10. glecaprevir

    MAVIRET

    ORAL FDA: approved · EMA: approved

    J05AP57

  11. glecaprevir + pibrentasvir

    MAVIRET AbbVie

    TGA: approved

  12. glecaprevir hydrate/pibrentasvir

    MAVIRET

    PMDA: approved

  13. glibenclamide

    DAONIL Sanofi-aventis Healthcare Pty Ltd

    EMA: approved · TGA: approved

    A10BB01

  14. gliclazide

    APX-GLICLAZIDE Servier Laboratories (Aust.) Pty.

    TGA: approved

  15. glimepiride

    ARX-GLIMEPIRIDE Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  16. glimiperide

    NMPA: clinical trials

  17. glipizide

    MELIZIDE Pfizer Australia Pty Ltd

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  18. glofitamab

    COLUMVI Hoffmann-La Roche

    EMA: approved · TGA: approved · NMPA: clinical trials

    L01FX28

  19. glofitamab-gxbm

    COLUMVI

    INJECTION FDA: approved

  20. glp-

    NMPA: clinical trials

  21. gls4

    NMPA: clinical trials

  22. glucagon

    BAQSIMI Amphastar France Pharmaceuticals

    INTRAVENOUS FDA: approved · EMA: approved

    H04AA01

  23. glucagon hydrochloride

    GLUCAGEN HYPOKIT NovoThirteen

    INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS FDA: approved · TGA: approved

  24. glucarpidase

    VORAXAZE

    INJECTION FDA: approved · EMA: approved

    V03AF09

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources